BioSpace News Archive

Medolife Rx, Inc. (“Medolife”), a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today preclinical trial results on its lead drug candidate Escozine®, a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions,

Cincinnati-based Jeanette Altenau, Director of Community Relations and Government Affairs at TriHealth, has received the St. George National Award from the American Cancer Society.

Inovytec, a developer of medical devices that address emergency and routine respiratory and cardiac care, announced today that it has signed a distribution agreement with Atlantic Diving Supply Inc. (ADS), a supplier of tactical and operational equipment, apparel and logistical services to the United States Department of Defense and other federal agencies.

Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today that its Sapphire™ infusion pump, accessories, and administration sets, have received EU Medical Device Regulation (MDR) 2017/45 certification.

SciSparc Ltd. (formerly known as Therapix Biosciences Ltd.) (OTCQB: SPRCY), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced it has entered an agreement with The Sheba Fund for Health Services and Research, to perform a pre-clinical study for the evaluation of the Company’s SCI-210

Albany Molecular Research, Inc., a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company is named on “America’s Best Mid-Sized Employers 2021” list published by Forbes.

Halberd Corporation’s Chairman, President & CEO, William A. Hartman, was interviewed recently on The Stock Day Podcast, hosted by Everett Jolly.

ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today announced that Mr. Brendan Brennan, CFO of ICON plc,

Moshe Rogosnitzky, heads Drug Rediscovery Group Ltd in Rehovot, Israel, focusing on the repurposing of generic drugs for diseases such as ophthalmic disorders, viral infections, insomnia, pain disorders, and opioid addiction.

Altasciences, a fully integrated early phase CRO/CDMO has started the expansion of their CDMO facility in Philadelphia, PA. The additional 35,000-square-foot building directly adjoins the current location, and will be fully renovated to meet the growing business needs.